J. Scott Wolchko
2014
In 2014, J. Scott Wolchko earned a total compensation of $799.4K as President, Chief Executive Officer and Director at Fate Therapeutics, a 72% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $41,850 |
|---|---|
| Option Awards | $433,568 |
| Salary | $310,000 |
| Stock Awards | $13,950 |
| Total | $799,368 |
Wolchko received $433.6K in option awards, accounting for 54% of the total pay in 2014.
Wolchko also received $41.9K in non-equity incentive plan, $310K in salary and $14K in stock awards.
Rankings
In 2014, J. Scott Wolchko's compensation ranked 8,529th out of 13,032 executives tracked by ExecPay. In other words, Wolchko earned more than 34.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,529 out of 13,032 | 35th |
Division Manufacturing | 3,169 out of 4,966 | 36th |
Major group Chemicals And Allied Products | 1,072 out of 1,686 | 36th |
Industry group Drugs | 849 out of 1,365 | 38th |
Industry Biological Products, Except Diagnostic Substances | 149 out of 236 | 37th |
Source: SEC filing on March 30, 2016.
Wolchko's colleagues
We found three more compensation records of executives who worked with J. Scott Wolchko at Fate Therapeutics in 2014.